Skip to content
GenoLensGenoLens

HSD3B2

Chr 1p12

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2

Aliases:
SDR11E2
MANE:
ENST00000369416.4

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Differences in sex development

    BIALLELIC, autosomal or pseudoautosomal
  • Congenital adrenal hypoplasia

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency

    0.82
  • congenital adrenal hyperplasia

    0.54
  • adrenal gland disorder

    0.37
  • hereditary disease

    0.19
  • ependymoma

    0.11
  • Cone rod dystrophy

    0.08
  • prostate cancer

    0.08
  • retinitis pigmentosa

    0.08
  • Leber congenital amaurosis

    0.08
  • achromatopsia

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2

3-beta-HSD is a bifunctional enzyme, that catalyzes the oxidative conversion of Delta(5)-ene-3-beta-hydroxy steroid, and the oxidative conversion of ketosteroids. The 3-beta-HSD enzymatic system plays a crucial role in the biosynthesis of all classes of hormonal steroids

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.